CENTRO NAC DE INVESTIGACIONES CARDIOVASCULARES CARLOS III F S P has a total of 19 patent applications. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are UNI LEIPZIG, UNIV MAASTRICHT and INSERM INSTITUTE NATIONAL DE LA SANTE ET DE LA RECH MEDICALE.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | United States | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Analysing materials | |
#3 | Microorganisms | |
#4 | Enzymes | |
#5 | Medical preparations | |
#6 | Peptides | |
#7 | Measuring microorganism processes | |
#8 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Oller Pedrosa Jorge | 4 |
#2 | Redondo Moya Juan Miguel | 4 |
#3 | Méndez-Barbero Nerea | 3 |
#4 | Sánchez Díaz Raquel | 2 |
#5 | Pérez-Villacastín Domínguez Julián | 2 |
#6 | Sancho Madrid David | 2 |
#7 | García Quintanilla Jorge | 2 |
#8 | Matesanz Marín Adela | 2 |
#9 | Saz Leal Paula | 2 |
#10 | Sánchez Madrid Francisco | 2 |
Publication | Filing date | Title |
---|---|---|
WO2021058548A1 | Antibodies for the diagnosis and/or treatment of atherosclerosis | |
WO2021058553A1 | Methods for the diagnosis of atherosclerosis | |
WO2020152163A1 | Improved cre/lox dna construct | |
WO2020089282A1 | Biomarkers of subclinical atherosclerosis | |
WO2019234189A1 | Enhanced trained immunity in myeloid cells by ship-1 inhibition | |
WO2019086683A1 | Inhibitors of membrane-type 4 matrix metalloproteinase (mt4-mmp) and its use in the treatment of diseases benefiting from an increase in the activity of patrolling monocytes | |
WO2019086626A1 | MIRNAs AND COMBINATIONS THEREOF FOR USE IN THE TREATMENT OF HUMAN B CELL NEOPLASIAS | |
EP3646889A1 | Iron oxide nanoparticles doped with copper | |
EP3636147A1 | Method for the identification of cardiac fibrillation drivers and/or the footprint of rotational activations using single optical or electrical signals without requiring panoramic simultaneous acquisition | |
WO2018138360A1 | Oxygen carrying blood substitutes and their use as delivery vehicles | |
AU2016396401A1 | In vitro method for identifying thoracic aortic aneurysms (TAA) in a subject | |
US2018355427A1 | Method for diagnosing cardiomyopathies |